ICH_ID,ICH_topic,ICH_subsection,ICH_Description,,,,,,Type,Link
Q1,Q1 Stability,Q1A(R2),Stability Testing of New Drug Substances and Products,,,,,,guideline,https://database.ich.org/sites/default/files/Q1A%28R2%29%20Guideline.pdf
Q1,Q1 Stability,Q1B,Stability Testing : Photostability Testing of New Drug Substances and Products,,,,,,guideline,https://database.ich.org/sites/default/files/Q1B%20Guideline.pdf
Q1,Q1 Stability,Q1C,Stability Testing for New Dosage Forms,,,,,,guideline,https://database.ich.org/sites/default/files/Q1C%20Guideline.pdf
Q1,Q1 Stability,Q1D,Bracketing and Matrixing Designs for Stability Testing of New Drug Substances and Products,,,,,,guideline,https://database.ich.org/sites/default/files/Q1D%20Guideline.pdf
Q1,Q1 Stability,Q1E,Evaluation of Stability Data,,,,,,guideline,https://database.ich.org/sites/default/files/Q1E%20Guideline.pdf
Q1,Q1 Stability,Q1F,Stability Data Package for Registration Applications in Climatic Zones III and IV,,,,,,guideline,https://database.ich.org/sites/default/files/Q1F_Stability_Guideline_WHO_2018.pdf
Q1,Q1 Stability,Q1/Q5C informal WG,Targeted Revisions of the ICH Stability Guideline Series,,,,,,,
Q2,Q2 Analytical Validation,Q2(R1),Validation of Analytical Procedures: Text and Methodology,,,,,,guideline,https://database.ich.org/sites/default/files/Q2%28R1%29%20Guideline.pdf
Q2 Q14,Shared Q2(R2)/Q14,Q2(R2)/Q14 EWG,Analytical Procedure Development and Revision of Q2 (R1) Analytical Validation,,,,,,,
Q3,Q3 Impurities,Q3A(R2),Impurities in New Drug Substances,,,,,,guideline,https://database.ich.org/sites/default/files/Q3A%28R2%29%20Guideline.pdf
Q3,Q3 Impurities,Q3B(R2),Impurities in New Drug Products,,,,,,guideline,https://database.ich.org/sites/default/files/Q3B%28R2%29%20Guideline.pdf
Q3,Q3 Impurities,Q3C(R8),Guideline for Residual Solvents,,,,,,,https://database.ich.org/sites/default/files/ICH_Q3C-R8_Guideline_Step4_2021_0422_1.pdf
Q3,Q3 Impurities,Q3C(R9) Maintenance EWG,Maintenance of the Guideline for Residual Solvents,,,,,,,
Q3,Q3 Impurities,Q3D(R2),Guideline for Elemental Impurities,,,,,,guideline,https://database.ich.org/sites/default/files/Q3D-R2_Guideline_Step4_2022_0308.pdf
Q3,Q3 Impurities,Q3D(R3) Maintenance EWG,Maintenance of the Guideline for Elemental Impurities,,,,,,,
Q3,Q3 Impurities,Q3D training,Implementation of Guideline for Elemental Impurities,,,,,,,
Q3,Q3 Impurities,Q3E EWG,Impurity: Assessment and Control of Extractables and Leachables for Pharmaceuticals and Biologics,,,,,,,
Q4,Q4 Pharmacopoeias,Q4A,Pharmacopoeial Harmonisation,,,,,,,
Q4,Q4 Pharmacopoeias,Q4B,Evaluation and Recommendation of Pharmacopoeial Texts for Use in the ICH Regions,,,,,,guideline,https://database.ich.org/sites/default/files/Q4B%20Guideline.pdf
Q4,Q4 Pharmacopoeias,Q4B Annex 1(R1),Residue on Ignition/Sulphated Ash General Chapter,,,,,,,
Q4,Q4 Pharmacopoeias,Q4B Annex 2(R1),Test for Extractable Volume of Parenteral Preparations General Chapter,,,,,,,
Q4,Q4 Pharmacopoeias,Q4B Annex 3(R1),Test for Particulate Contamination: Sub-Visible Particles General Chapter,,,,,,,
Q4,Q4 Pharmacopoeias,Q4B Annex 4A(R1),Microbiological Examination of Non-Sterile Products: Microbial Enumeration Tests General Chapter,,,,,,,
Q4,Q4 Pharmacopoeias,Q4B Annex 4B(R1),Microbiological Examination of Non-Sterile Products: Tests for Specified Micro-Organisms General Chapter,,,,,,,
Q4,Q4 Pharmacopoeias,Q4B Annex 4C(R1),Microbiological Examination of Non-Sterile Products: Acceptance Criteria for Pharmaceutical Preparations and Substances for Pharmaceutical Use General Chapter,,,,,,,
Q4,Q4 Pharmacopoeias,Q4B Annex 5(R1),Disintegration Test General Chapter,,,,,,,
Q4,Q4 Pharmacopoeias,Q4B Annex 6,Uniformity of Dosage Units General Chapter,,,,,,,
Q4,Q4 Pharmacopoeias,Q4B Annex 7(R2),Dissolution Test General Chapter,,,,,,,
Q4,Q4 Pharmacopoeias,Q4B Annex 8(R1),Sterility Test General Chapter,,,,,,,
Q4,Q4 Pharmacopoeias,Q4B Annex 9(R1),Tablet Friability General Chapter,,,,,,,
Q4,Q4 Pharmacopoeias,Q4B Annex 10(R1),Polyacrylamide Gel Electrophoresis General Chapter,,,,,,,
Q4,Q4 Pharmacopoeias,Q4B Annex 11,Capillary Electrophoresis General Chapter,,,,,,,
Q4,Q4 Pharmacopoeias,Q4B Annex 12,Analytical Sieving General Chapter,,,,,,,
Q4,Q4 Pharmacopoeias,Q4B Annex 13,Bulk Density and Tapped Density of Powders General Chapter,,,,,,,
Q4,Q4 Pharmacopoeias,Q4B Annex 14,Bacterial Endotoxins Test General Chapter,,,,,,,
Q4,Q4 Pharmacopoeias,Q4B FAQs,Frequently Asked Question,,,,,,,https://database.ich.org/sites/default/files/Q4B_FAQs_FAQs.pdf
Q5,Q5 Quality of Biotechnological Products,Q5A(R1),Viral Safety Evaluation of Biotechnology Products Derived from Cell Lines of Human or Animal Origin,,,,,,guideline,https://database.ich.org/sites/default/files/Q5A%28R1%29%20Guideline_0.pdf
Q5,Q5 Quality of Biotechnological Products,Q5A(R2) EWG,Viral Safety Evaluation of Biotechnology Products Derived from Cell Lines of Human or Animal Origin,,,,,,,
Q5,Q5 Quality of Biotechnological Products,Q5B,Analysis of the Expression Construct in Cells Used for Production of r-DNA Derived Protein Products,,,,,,guideline,https://database.ich.org/sites/default/files/Q5B%20Guideline.pdf
Q5,Q5 Quality of Biotechnological Products,Q5C,Quality of Biotechnological Products: Stability Testing of Biotechnological/Biological Products,,,,,,guideline,https://database.ich.org/sites/default/files/Q5C%20Guideline.pdf
Q5,Q5 Quality of Biotechnological Products,Q5D,Derivation and Characterisation of Cell Substrates Used for Production of Biotechnological/Biological Products,,,,,,guideline,https://database.ich.org/sites/default/files/Q5D%20Guideline.pdf
Q5,Q5 Quality of Biotechnological Products,Q5E,Comparability of Biotechnological/Biological Products Subject to Changes in their Manufacturing Process,,,,,,guideline,https://database.ich.org/sites/default/files/Q5E%20Guideline.pdf
Q6,Q6 Specifications,Q6A,Specifications : Test Procedures and Acceptance Criteria for New Drug Substances and New Drug Products: Chemical Substances,,,,,,guideline,https://database.ich.org/sites/default/files/Q6A%20Guideline.pdf
Q6,Q6 Specifications,Q6B,Specifications : Test Procedures and Acceptance Criteria for Biotechnological/Biological Products,,,,,,guideline,https://database.ich.org/sites/default/files/Q6B%20Guideline.pdf
Q7,Q7 Good Manufacturing Practice,Q7,Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients,,,,,,guideline,https://database.ich.org/sites/default/files/Q7%20Guideline.pdf
Q7,Q7 Good Manufacturing Practice,Q7 Q&As,Questions and Answers: Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients,,,,,,,
Q8,Q8 Pharmaceutical Development,Q8(R2),Pharmaceutical Development,,,,,,guideline,https://database.ich.org/sites/default/files/Q8%28R2%29%20Guideline.pdf
Q8 Q9 Q10,Shared Q8/9/10,Q8/9/10 Q&As (R4),Q8/Q9/Q10 - Implementation,,,,,,,
Q9,Q9 Quality Risk Management,Q9,Quality Risk Management,,,,,,guideline,https://database.ich.org/sites/default/files/Q9%20Guideline.pdf
Q9,Q9 Quality Risk Management,Q9(R1) EWG,Quality Risk Management,,,,,,guideline,https://database.ich.org/sites/default/files/ICH_Q9-R1_Document_Step2_Guideline_2021_1118.pdf
Q8 Q9 Q10,Shared Q8/9/10,Q8/9/10 Q&As (R4),Q8/Q9/Q10 - Implementation,,,,,,,https://database.ich.org/sites/default/files/Q8_Q9_Q10_Q%26As_R4_Q%26As_0.pdf
Q10,Q10 Pharmaceutical Quality System,Q10,Pharmaceutical Quality System,,,,,,guideline,https://database.ich.org/sites/default/files/Q10%20Guideline.pdf
Q8 Q9 Q10,Shared Q8/9/10,Q8/9/10 Q&As (R4),Q8/Q9/Q10 - Implementation,,,,,,,https://database.ich.org/sites/default/files/Q8_Q9_Q10_Q%26As_R4_Q%26As_0.pdf
Q11,Q11 Development and Manufacture of Drug Substances,Q11,Development and Manufacture of Drug Substances (Chemical Entities and Biotechnological/Biological Entities),,,,,,guideline,https://database.ich.org/sites/default/files/Q11%20Guideline.pdf
Q11,Q11 Development and Manufacture of Drug Substances,Q11 Q&As,Questions & Answers: Selection and Justification of Starting Materials for the Manufacture of Drug Substances,,,,,,,https://database.ich.org/sites/default/files/Q11_Q%26As_Q%26As.pdf
Q12,Q12 Lifecycle Management,Q12,Technical and Regulatory Considerations for Pharmaceutical Product Lifecycle Management,,,,,,guideline,https://database.ich.org/sites/default/files/Q12_Guideline_Step4_2019_1119.pdf
Q12,Q12 Lifecycle Management,Q12 IWG,Training on Regulatory and Technical Considerations for Pharmaceutical Product Lifecycle Management,,,,,,,
Q13,Q13 Continuous Manufacturing of Drug Substances and Drug Products,Q13 EWG,Continuous Manufacturing of Drug Substances and Drug Products,,,,,,guideline,https://database.ich.org/sites/default/files/ICH_Q13_Step2_DraftGuideline_%202021_0727.pdf
Q2 Q14,Shared Q2(R2)/Q14,Q2(R2)/Q14 EWG,Analytical Procedure Development and Revision of Q2 (R1) Analytical Validation,,,,,,,